KIRSTEN FURL: Open Payments
NPI 1831648898 · FLORESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,817 in 67 payments from 10 companies in 2025. Trend: 2023 $25,572 · 2024 $16,272 · 2025 $7,817
Speaker / faculty: $4,795Travel & lodging: $1,810Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| EVOKE PHARMA, INC. | 11 | $6,888 |
| ABBVIE INC. | 18 | $313 |
| Madrigal Pharmaceuticals | 11 | $187 |
| Janssen Biotech, Inc. | 10 | $174 |
| Phathom Pharmaceuticals, Inc. | 7 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Ardelyx, Inc. | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $14 |
Products named: GIMOTI, REZDIFFRA, TREMFYA, MAVYRET, VOQUEZNA, RINVOQ, IBSRELA, CREON.
Industry payments across TX — which companies pay providers there.
